HNRNPL and non-small cell lung carcinoma: For example, Goehe et al. showed that hnRNP L is required for the tumorigenic capacity of non-small-cell lung cancer cell by promoting the skipping of caspase 9 exons 3–6 and the expression of caspase 9b, an antiapoptotic isoform of caspase 9 [18].